Relay Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cambridge, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Relay Therapeutics, Inc. has filed 494 SEC EDGAR filings since 22 May 2020

SEC filing history

Showing 176-200 of 494 matching filings.

Per page
25
Current page
8
DEF 14A File 001-39385

DEF 14A

Filing date
23 Apr 2024
Reporting date
03 Jun 2024
Next action
Verify source filing
4

4

Filing date
29 Mar 2024
Reporting date
27 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
29 Mar 2024
Reporting date
27 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
29 Mar 2024
Reporting date
27 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
29 Mar 2024
Reporting date
27 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-277278

S-8

Filing date
22 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-92097

SC 13G/A filing

Filing date
14 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-92097

SC 13G filing

Filing date
14 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-92097

SCHEDULE 13G/A

Filing date
13 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
31 Jan 2024
Reporting date
29 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
31 Jan 2024
Reporting date
29 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
31 Jan 2024
Reporting date
29 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
31 Jan 2024
Reporting date
29 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-92097

SC 13G/A filing

Filing date
26 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-92097

SC 13G/A filing

Filing date
23 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
18 Jan 2024
Reporting date
16 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
18 Jan 2024
Reporting date
16 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
18 Jan 2024
Reporting date
16 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
18 Jan 2024
Reporting date
16 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
18 Jan 2024
Reporting date
16 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
424B7 File 333-258768

424B7

Filing date
10 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-502011

D filing

Filing date
10 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .